3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and furosemide

3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with furosemide in 2 studies

Compound Research Comparison

Studies (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)	Trials (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)	Recent Studies (post-2010) (3-carboxy-4-methyl-5-propyl-2-furanpropionic acid)	Studies (furosemide)	Trials (furosemide)	Recent Studies (post-2010) (furosemide)
100	6	38	13,631	1,358	2,486

Protein Interaction Comparison

Protein	Taxonomy	furosemide (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1	Homo sapiens (human)	3.76
Corticosteroid 11-beta-dehydrogenase isozyme 1	Mus musculus (house mouse)	3.76
Broad substrate specificity ATP-binding cassette transporter ABCG2	Homo sapiens (human)	3.2

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barlow, JW; Curtis, AJ; Lim, CF; Stockigt, JR; Topliss, DJ; Wynne, KN	1
Kawai, K; Nishii, R; Nishio, T; Takamura, N; Tokunaga, J; Yoshimoto, M	1

Trials

1 trial(s) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and furosemide

Article	Year
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:7 Topics: Adult; Aged; Barbiturates; Binding Sites; Carbon Radioisotopes; Diazepam; Diuretics; Fatty Acids, Nonesterified; Female; Furans; Furosemide; Hippurates; Humans; Indican; Kidney Failure, Chronic; Male; Middle Aged; Propionates; Protein Binding; Renal Dialysis; Serum Albumin; Treatment Outcome; Warfarin	2008

Article

Year

Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, Volume: 23, Issue:7

Topics: Adult; Aged; Barbiturates; Binding Sites; Carbon Radioisotopes; Diazepam; Diuretics; Fatty Acids, Nonesterified; Female; Furans; Furosemide; Hippurates; Humans; Indican; Kidney Failure, Chronic; Male; Middle Aged; Propionates; Protein Binding; Renal Dialysis; Serum Albumin; Treatment Outcome; Warfarin

2008

Other Studies

1 other study(ies) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and furosemide

Article	Year
A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum. Metabolism: clinical and experimental, 1993, Volume: 42, Issue:11 Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine	1993

Article

Year

A naturally occurring furan fatty acid enhances drug inhibition of thyroxine binding in serum.

Metabolism: clinical and experimental, 1993, Volume: 42, Issue:11

Topics: Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Binding, Competitive; Diflunisal; Dose-Response Relationship, Drug; Drug Interactions; Fatty Acids, Nonesterified; Furans; Furosemide; Humans; Oleic Acid; Oleic Acids; Phenylacetates; Prealbumin; Propionates; Thyroxine; Thyroxine-Binding Proteins; Triiodothyronine

1993